Company Filing History:

20 out of 125

Forma Therapeutics, Inc.

patents

4 out of 16

Foghorn Therapeutics Inc.

patents

2 out of 15

Valo Early Discovery, Inc.

Years Active: 2016-2025

Loading Chart...

28 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12441726 - Compounds and uses thereof (2025-10-14),

2. 12383560 - Compounds and uses thereof (2025-08-12),

3. 12378242 - Inhibiting CREB binding protein (CBP) (2025-08-05),

4. 12351577 - Inhibiting cyclic AMP-responsive element-binding protein (CREB) (2025-07-08),

5. 12252490 - Inhibiting deubiquitinase USP25 and USP28 (2025-03-18),

6. 12139487 - Compounds and uses thereof (2024-11-12),

7. 11787803 - Tetrahydro-imidazo quinoline compositions as CBP/P300 inhibitors (2023-10-17),

8. 11497752 - Compounds and uses thereof (2022-11-15),

9. 11325917 - Thienopyrazine carboxamides as ubiquitin-specific protease inhibitors (2022-05-10),

10. 11292791 - Tetrahydro-imidazo quinoline compositions as CBP/P300 inhibitors (2022-04-05),

11. 11267805 - Solid forms of (4-(2-fluoro-4-(1-methyl-1H-benzo[d]imidazol-5-yl)benzoyl) piperazine-1-yl)(1-hydroxycyclopropyl)methanone (2022-03-08),

12. 11254674 - Inhibiting CREB binding protein (CBP) (2022-02-22),

13. 11111229 - Tetrahydroquinoline compositions as BET bromodomain inhibitors (2021-09-07),

14. 11084831 - Benzopiperazine compositions as BET bromodomain inhibitors (2021-08-10),

15. 10995078 - Compounds and compositions for inhibition of FASN (2021-05-04),

Title: The Innovative Journey of Shawn E R Schiller

Introduction: Shawn E R Schiller is a distinguished inventor based in Haverhill, MA, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Shawn E R Schiller holds several patents in various technological domains, showcasing his versatility and ingenuity in creating novel solutions for complex problems.

Career Highlights: With a career spanning over two decades, Shawn E R Schiller has consistently pushed the boundaries of innovation, leading to the development of cutting-edge technologies that have revolutionized industries.

Collaborations: Throughout his career, Shawn E R Schiller has collaborated with leading research institutions, universities, and tech companies, fostering a culture of innovation and knowledge sharing.

Conclusion: Shawn E R Schiller's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors and technologists, leaving an indelible mark on the world of technology.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

4 patents (EPO):

Please report any incorrect information to support@idiyas.com

5 patents pending (EPO):

Please report any incorrect information to support@idiyas.com